Seeking Alpha

Canaccord Genuity analyst Randall Stanicky lines up three specialty pharmaceutical stocks with...

Canaccord Genuity analyst Randall Stanicky lines up three specialty pharmaceutical stocks with strong catalyst-driven upside potential before year-end: (1) Teva Pharmaceuticals (TEVA -0.3%) on generic Lipitor potential; (2) Inhibitex (INHX -0.1%) ahead of top-line results from INX-189; (3) Raptor (RPTP +0.3%) due to key six-month tolerability data set to be released in Dec.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs